Irtuins: Common targets in aging and in neurodegeneration

Rita Machado de Oliveira, Teresa F. Pais, Tiago Fleming Outeiro

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)

Abstract

Aging has been a subject of interest since primordial times. More recently, it became clear that aging is the major known risk factor for several neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. A major focus in the field of aging is to examine whether the genetic regulators of lifespan also regulate the trigger and/or progression of age-related disorders. Sirtuins, which belong to the Sir2 family of NAD+-dependent deacetylases, are known to regulate longevity in yeast, worms, and flies. In mammals, there are seven homologs of the yeast Sir2, Sirt1-7. Therefore, the challenge now is to unravel howthe seven mammalian Sir2 proteins communicate to regulate the cross talk between aging and the onset and progression of age-related disorders. Here, we review how sirtuins contribute for aging and, in particular, for neurodegeneration and how they are becoming attractive targets for therapeutic intervention.

Original languageEnglish
Pages (from-to)1270-1280
Number of pages11
JournalCurrent Drug Targets
Volume11
Issue number10
DOIs
Publication statusPublished - 2010
Externally publishedYes

Keywords

  • Aging
  • Alzheimer's disease
  • Neurodegeneration
  • Parkinson's disease
  • Sirtuins
  • Therapeutic targets

Fingerprint

Dive into the research topics of 'Irtuins: Common targets in aging and in neurodegeneration'. Together they form a unique fingerprint.

Cite this